BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27349987)

  • 21. Advanced chronic renal disease is an independent risk factor for inpatient mortality following transjugular intrahepatic portosystemic shunt procedure.
    Li R; Sarin S
    Eur J Gastroenterol Hepatol; 2024 Mar; 36(3):332-337. PubMed ID: 38179873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
    Artru F; Moschouri E; Denys A
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101858. PubMed ID: 34999250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients.
    Qi X; Han G; Yin Z; He C; Wang J; Guo W; Niu J; Zhang W; Bai M; Fan D
    Dig Dis Sci; 2012 Apr; 57(4):1072-82. PubMed ID: 22147244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minilaparotomy-Assisted Transmesenteric-Transjugular Intrahepatic Portosystemic Shunt: Comparison with Conventional Transjugular Approach.
    Jalaeian H; Talaie R; D'Souza D; Taleb S; Noorbaloochi S; Flanagan S; Hunter D; Golzarian J
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1413-9. PubMed ID: 27272888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device.
    Lauermann J; Potthoff A; Mc Cavert M; Marquardt S; Vaske B; Rosenthal H; von Hahn T; Wacker F; Meyer BC; Rodt T
    Cardiovasc Intervent Radiol; 2016 Apr; 39(4):547-56. PubMed ID: 26404629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient.
    Attia D; Rodt T; Marquardt S; Hinrichs J; Meyer BC; Gebel M; Wacker F; Manns MP; Potthoff A
    Abdom Radiol (NY); 2019 Mar; 44(3):1127-1134. PubMed ID: 30288582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children.
    Lv Y; He C; Guo W; Yin Z; Wang J; Zhang B; Meng X; Cai J; Luo B; Wu F; Niu J; Fan D; Han G
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):233-41. PubMed ID: 26381818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
    Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt reduces hospital care burden in patients with decompensated cirrhosis.
    Ballester MP; Lluch P; Gómez C; Capilla M; Tosca J; Martí-Aguado D; Guijarro J; Mínguez M
    Intern Emerg Med; 2021 Sep; 16(6):1519-1527. PubMed ID: 33400160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of symptomatic portal hypertension].
    Krajina A; Hůlek P; Eliás P; Michl A; Zizka J; Nozicka J; Vanásek T; Lojík M; Niangová I; Volfová M; Pozler O; Erben J; Papík Z; Bures J
    Cas Lek Cesk; 1996 Sep; 135(18):584-8. PubMed ID: 8998798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discharge dispositions, complications, and costs of hospitalization in spinal cord tumor surgery: analysis of data from the United States Nationwide Inpatient Sample, 2003-2010.
    Sharma M; Sonig A; Ambekar S; Nanda A
    J Neurosurg Spine; 2014 Feb; 20(2):125-41. PubMed ID: 24286530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.
    Kwan SW; Allison SK; Gold LS; Shin DS
    J Vasc Interv Radiol; 2018 Dec; 29(12):1705-1712. PubMed ID: 30392803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.
    Saugel B; Mair S; Meidert AS; Phillip V; Messer M; Nennstiel S; Berger H; Gaa J; Wagner JY; Schneider H; Schmid RM; Huber W
    J Crit Care; 2014 Dec; 29(6):1001-5. PubMed ID: 25220530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular intrahepatic portosystemic shunt versus H-graft portacaval shunt in the management of bleeding varices: a cost-benefit analysis.
    Rosemurgy AS; Bloomston M; Zervos EE; Goode SE; Pencev D; Zweibel B; Black TJ
    Surgery; 1997 Oct; 122(4):794-9; discussion 799-800. PubMed ID: 9347858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.
    Charilaou P; Devani K; Petrosyan R; Reddy C; Pyrsopoulos N
    Dig Dis Sci; 2020 Nov; 65(11):3378-3388. PubMed ID: 32062714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
    Njei B; McCarty TR; Laine L
    J Gastroenterol Hepatol; 2017 Apr; 32(4):852-858. PubMed ID: 27624167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.